TABLE 2

Cardiovascular Biomarkers, IMT, and TBR Values of Study Subjects Stratified by hsCRP and LDL-C Level

	hsCRP
	<2 mg/L		≥2 mg/L
Biomarker	LDL-C < 130 mg/dL (n = 30)	LDL-C ≥ 130 mg/dL (n = 30)	LDL-C < 130 mg/dL (n = 30)	LDL-C ≥ 130 mg/dL (n = 30)	P
Lp-PLA₂ (ng/mL)	226.4 ± 97.7^*	138.2 ± 43.4^†	160.4 ± 67.0^†	161.9 ± 52.0^†	<0.01
MCP-1 (pg/mL)	247.3 ± 64.9	301.0 ± 152.2	279.1 ± 144.6	314.9 ± 143.1	0.25
Mean IMT (mm)	0.62 ± 0.09^*	0.69 ± 0.17^*,^†	0.65 ± 0.18^*	0.75 ± 0.15^†	0.01
Maximum IMT (mm)	0.74 ± 0.12^*	0.83 ± 0.20^*,^†	0.78 ± 0.24^*	0.92 ± 0.20^†	<0.01
Mean SUV	1.57 ± 0.22^*,^†	1.54 ± 0.21^*	1.62 ± 0.20^*,^†	1.72 ± 0.26^†	0.01
Maximum SUV	1.66 ± 0.22^*	1.67 ± 0.24^*	1.75 ± 0.21^*,^†	1.88 ± 0.30^†	<0.01
Mean TBR	1.18 ± 0.10^*	1.08 ± 0.08^†	1.20 ± 0.11^*	1.46 ± 0.22^‡	<0.01
Maximum TBR	1.12 ± 0.10^*	1.16 ± 0.05^*	1.29 ± 0.13^†	1.61 ± 0.22^‡	<0.01

↵*,†,‡ No statistical difference between 2 groups, based on Tukey's HSD post hoc analysis.
Data are expressed as mean ± SD. P value for overall difference among groups was calculated from ANOVA.